Effect of retinoic acid on integrin receptors of B16F10 melanoma cells

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 1, 2000, Pages 81-87

  Sengupta, S ^a   Ray, S ^a   Chattopadhyay, N ^a   Biswas, N ^a   Chatterjee, A ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

All trans retinoic acid; Extracellular matrix proteins; Integrin; Metastasis

Indexed keywords

COLLAGENASE; INTEGRIN RECEPTOR; LAMININ; RETINOIC ACID; VITRONECTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; MELANOMA; METASTASIS INHIBITION; METASTASIS POTENTIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTEGRINS; MELANOMA; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034030545     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fidler I.J., Hart I.R.: Biological diversity in metastatic neoplasm: Origins and implications. Science 217 : 998-1003, 1982.
2. Liotta L.A.: Tumor invasion and metastasis-role of basement membrane . Am.J.Pathol. 117: 338-348, 1984.
3. Liotta L.A.:Tumor invasion and metastasis - role of extracellular matrix. Cancer Res. 46: 1-7, 1986.
4. Hynes R.O.: Integrins: A family of cell surface receptors. Cell. 48: 549-554, 1987.
5. Juliano R.L.: Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochem.Biophys.Acta 907: 261-278, 1987.
6. Chan B.M., Matsuura N., Takada Y., Zetter B.R., Hemler M.E.: in vitro and in vivo consequences of VLA-2 expression in rhabdomyosarcoma cells. Science 251: 1600-1602, 1991.
7. Castronovo V., Campo E., van-den-Brule F.A., Claysmith A.P., Cioce V., Liu F.T., Fernandez P.L., Sobel M.E.: Inverse modulation of steady state messenger RNA levels of two nonintegrin laminin binding proteins in human colon carcinoma. J.Natl.Cancer.Inst. 84: 1161-1169, 1992.
8. Gomez M., Navarro P., Quintanilla M., Cano A.: Expression alpha 6 beta 4 integrin increases during malignant conversion of mouse epidermal keratinocytes: association of beta 4 subunit to the cytokeratin fraction. Exp.Cell.Res. 201: 250-261, 1992.
9. Favrot M.C., Combaret V., Goillot E., Tabone E., Bouffet E., Dolbeau D., Bouvier R., Coze C., Michon J., Philip T.: Expression of integrin receptors in 45 neuroblastoma specimens. Int.J.Cancer 49: 347-355, 1991.
10. Redfern C.P.F., Lovat P.E., Malcom A.J., Pearson, A.D.J.: Gene expression and neuroblastoma cell differentiation in response to retinoic acid. Differential effects of 9 cis and all trans retinoic acid. Eur.J.Cancer 31A: 486-494, 1995.
11. Lippman S.M., Kessler J.F., Meyskers F.L.Jr.: Retinoids as preventive and therapeutic anticancer agents. Cancer treat.Rep. 71: 391, 1987.
12. Lotan R., Xu X.C., Lippman S.M.: Suppression of retinoic acid receptor beta in premalignant oral lesions and its upregulation by isotreitonin. New Engl.Med. 332: 1405-1410.
13. Lipmann S.M., Spitz M.R., Huber M., Hong W.K.: Strategies for chemoprevention study of premalignant lesions and second primary tumors in the head and neck. Curr.Opin.Oncol. 7: 234-241, 1995.
14. Shin D.M., Kim J., Ro J.Y., Hittelman J., Roth J.A., Hong W.K., Hittleman W.N.: Activation of p53 gene expression in premalignant lesions during head and neck carcinogenesis. Cancer Res. 54: 321-326, 1994.
15. Tallman M.S.: Differentiating therapy in acute myeloid leukemia. Leukemia 10: 1262-1268, 1996.
16. Oridate N., Esumi N., Lotan D., Hing W.K., Rochette -Egly, C., Chambon P., Lotan R.: Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells. Oncogene 12: 2019-2028, 1996.
17. Desai S.H., Niles R.M.: Characterisation of retinoic acid induced AP-1 activity in B16 F10 mouse melanona cells. J.Biol.Chem. 272: 12809-12815, 1997.
18. Ananthaswamy H.A., Price J.E., Tainsky M.A., Goldberg L.H., Bales E.S.: Correlation between Ha-ras gene amplification and spontaneous metastasis in N1H-3T3 cells transfected with genomic DNA from human skin cancers. Clin. Exp. Metas. 7:, 301-313, 1989.
19. Bodary S.C., McLean J.W.: The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J. Biol. Chem. 265: 5938-5941. 1990.
20. Wang D.H., Zhou G., Birkenmeier T.M., Gong J., Sun L.Z., Brattain M.G.: Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells. J. Biol. Chem. 270: 14154-14159, 1995.
21. Kramer R.H., Bensch K.G., Wong J.: Invasion of reconstituted basement matrix by metastatic human tumor cells. Cancer Res. 46: 1980-1989, 1986.
22. Laemmli U.K.: Cleavage of the structural proteins during he assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
23. Unemoni E.N., Werb Z.: Collagenase expression and endogenous activation in rabbit synovial fibroblasts stimulated by the cacium ionophore A23187. J.Biol.Chem. 263: 16252-16259, 1988.
24. Hendrix M.J.C., Wood W.R., Seftor E.A., Lotan D., Nakajima M., Misiorowsi R.L., Seftor R.E.B., Stetler-Stevenson W.G., Beviacqua S.J., Liotta L.A., Sobel M.E., Raz A., Lotan R.: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptors. Cancer Res. 50: 4121-4130, 1990.
25. Song S.Y., Nomizu M., Yamada Y., Kleinman H.K.: Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16 F10 melanoma cells. Intl.J.Cancer 71: 436-441, 1997.
26. Lugassu C., Eyden B.P., Christensen L., Escande J.P.: Angiotumoral complex in human malignant melanona characterised by free laminin: Ultrastructural and immunohistochemical observations. J.Submicros.Cytol.Pathol. 29: 19-28, 1997.
27. Chen W.T., Wang H., Hasegawa T., Yamada K.M.: Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin and synthetic peptides. J.Biol.Chem. 103: 1649-1661, 1986.
28. Garbisa S., Pozzatti R., Muschel R.J., Saffiotti U., Ballin M., Goldfarb R.H., Khoury G., Liotta L.A.: Secretion of type IV collagenolytic protease and metastatic phenotype induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res. 47: 1523-1528, 1987.
29. Yamada K.M., Miyamoto S.: Integrin transmembrane signalling and cytoskeletal control. Curr.Opin.Cell Biol. 7: 681-689, 1995.
30. Damsky C.H., Werb Z.: Signal transduction by integrin receptors for extracellular matrix: cooperative procelling of extracellular information. Curr.Opin.Cell Biol. 5: 819-831, 1992.
31. Humphries M.J., Moild A.P., Tuckwell D.S.: Dynamic aspects of adhesion receptor function - integrins both twist and shout. Bioessays 15: 391-397, 1993.
32. Ura H., Bonfil R.D., Reich R., Reddel R., Pfeifer A., Harris C.C., Klein A.J.P.: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic,invasive and metastatic abilities of oncogene trasformed human bronchila epithelial cells. Cancer Res. 49: 4615-4621, 1989.
33. Miganatti P., Robbins E., Rifkin D.: Tumor invasion rough the amniotic membrane.Requirement for a proteinase cascade. Cell 47: 487-498, 1986.
34. Monteagudo C., Merino M., San-Juan J., Liotta L.A., Stetler-Stevenson W.: Immunohistochemical distribution of type IV collagenase in normal,benign and malignant breast tissue. Am. J. Pathol. 138: 585-592, 1990.
35. Seftor R.E., Seftor E.A., Gehlson K.R., Stetler-Stevenson W.G., Brown P.D., Ruoslahti E., Hendrix M.J.: Role of alpha v beta 3 intrgrin in human melanoma cell invasion. Proc. Natl. Acad. Sce. U.S.A. 89: 1557-1561, 1992.
36. Guoun V., Tucker G.C., Kraus-Berthier L., Atassi G., Kieffer N.: Upgraded expression of the beta 3 integrin and the 92kd gelatinase in human HT-144 melanoma cell tumors grown in nude mice. Int. J. Cancer 68: 650-662, 1996.